Search

everythinglearnresearchcommunity

for

Search:↓

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Underactive bladder is hard to diagnose and treat, needing more research.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Physical symptoms in depression can reveal underlying medical conditions.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Treatment during development affects hormone balance and sexual behavior in male rats.

Managing telogen effluvium is challenging due to limited scientific evidence.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

A functional medicine approach may help long COVID patients by focusing on adrenal fatigue, gut health, and vitamin D deficiency, using diagnostic tools and lifestyle changes.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

FFA patients have fewer melanocytes and thinner skin compared to others.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Effective sleep apnea treatment may reverse cognitive decline in Alzheimer's.

Facial care products are not linked to causing frontal fibrosing alopecia.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

Trichostasis spinulosa is common but often underdiagnosed, mainly affecting women's faces.

Finasteride may cause depression and affect brain and gut health in male rats.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Finasteride can cause serious physical, mental, and sexual side effects, even after stopping the treatment.

Medications for benign prostatic syndrome can cause cognitive issues and depression.